Answer
Levobupivacaine hydrochloride is metabolised in the liver, so it should be used cautiously in patients with liver disease or reduced liver blood flow, such as alcoholics or cirrhotics.
Sources for this answer
- Levobupivacaine 7.5 mg/ml solution for injection/infusionMartindale Pharma, an Ethypharm Group Company · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked